28.03.2014
- GlaxoSmithKline (GSK), the UK's largest pharmaceutical company, has provisionally withdrawn its marketing authorization application to the European Medicines Agency (EMA) for the...
28.03.2014
- U.S. healthcare giant Baxter International has announced plans to split its pharmaceuticals and its medical devices businesses into two publicly traded companies from mid-2015...
21.03.2014
- Novo Nordisk should still be able to introduce its long-acting insulin Tresiba on the U.S. market before rival products, despite being hit by a delay, the CEO of the Danish...
20.03.2014
- The European Medicines Agency, EMA, has said it will try out a new process of staggered drug approvals in a bid to accelerate access to new medicines. The decision to pilot so...
18.03.2014
- Merck Serono, the biopharmaceutical division of Germany's Merck KGaA, has named Meeta Gulyani as head of strategy and global franchises, effective May 7. She will be based in...
18.03.2014
- Novozymes Biopharma, part of Novozymes A/S, has announced a collaboration with Janssen Research & Development, LLC (Janssen). The agreement will enable Janssen to evaluate...
12.03.2014
- DPx Holdings, the new global contract development and manufacturing joint venture of Dutch chemical producer DSM with U.S. private equity firm JLL Partners, was launched on Mar. 11...
12.03.2014
- BayerHealthcare plans to invest more than €500 million at its sites in Wuppertal and Leverkusen, Germany, to expand capacity for production of its recombinant factor VIII...
